v3.23.3
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2023
Restatement of Previously Issued Financial Statements [Abstract]  
Schedule of Unaudited Condensed Consolidated Financial Statements The impact of the restatement on the Company’s unaudited condensed consolidated financial statements is reflected in the following table:
 

As Previously
Reported

 

Adjustment

 

As Restated

Condensed Consolidated Balance Sheet for the three months ended March 31, 2023 (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

Convertible Promissory Note – Related Party

 

$

257,014

 

 

$

1,882,986

 

 

$

2,140,000

 

Additional paid in capital

 

$

563,136

 

 

$

(563,136

)

 

$

—

 

Accumulated deficit

 

$

(15,207,806

)

 

$

(1,319,850

)

 

$

(16,527,656

)

Total Liabilities

 

$

15,881,107

 

 

$

1,882,986

 

 

$

17,764,093

 

Total Stockholders’ Equity (deficit)

 

$

(14,643,951

)

 

$

(1,882,986

)

 

$

(16,526,937

)

   

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statement of Operations for the three months ended March 31, 2023 (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of convertible promissory notes

 

$

1,319,850

 

 

$

(1,319,850

)

 

 

—

 

Total other income (expense)

 

$

909,732

 

 

$

(1,319,850

)

 

$

(410,118

)

Income before provision for income taxes

 

$

81,106

 

 

$

(1,319,850

)

 

$

(1,238,744

)

Net Income (loss)

 

$

(374,842

)

 

$

(1,319,850

)

 

$

(1,694,692

)

   

 

 

 

 

 

 

 

 

 

 

 

EPS:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted avg shares outstanding, Class A common stock

 

 

21,188,697

 

 

 

—

 

 

 

21,188,697

 

Basic and diluted net loss per share, Class A common stock

 

$

(0.01

)

 

 

(0.05

)

 

 

(0.06

)

   

 

 

 

 

 

 

 

 

 

 

 

Weighted avg shares outstanding, Class B common stock

 

 

7,187,500

 

 

 

—

 

 

 

7,187,500

 

Basic and diluted net loss per share, Class B common stock

 

$

(0.01

)

 

 

(0.05

)

 

 

(0.06

)

   

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statement of Equity for the three months ended March 31, 2023 (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

Proceeds received in excess of initial fair value of Convertible Promissory Note

 

$

563,136

 

 

$

(563,136

)

 

$

—

 

Net Income (loss)

 

$

(374,842

)

 

$

(1,319,850

)

 

$

(1,694,692

)

Accretion for Class A common stock to redemption amount-APIC

 

$

(2,355,234

)

 

$

—

 

 

$

(2,355,234

)

Accumulated Deficit

 

$

(15,207,806

)

 

$

(1,319,850

)

 

$

(16,527,656

)

Total Stockholders Equity (deficit)

 

$

(14,643,951

)

 

$

(1,882,986

)

 

$

(16,526,937

)

   

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statement of Cash Flows for the three months ended March 31, 2023 (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(374,842

)

 

$

(1,319,850

)

 

$

(1,694,692

)

Change in fair value of convertible promissory note

 

$

(1,319,850

)

 

$

1,319,850

 

 

$

—

 

   

 

 

 

 

 

 

 

 

 

 

 

Non Cash:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds received in excess of initial fair value of Convertible Promissory Note – Shares at initial borrowing

 

$

563,136

 

 

$

(563,136

)

 

$

—